BD Medical - Pharmaceutical Systems manufactures and sells prefillable drug delivery systems to pharmaceutical and biotech companies.
Drug Delivery Systems
Committed to drug delivery excellence. Our vision is to enable customer success with high quality and innovative drug delivery solutions that improve patient well-being.
- Overview
- Products
- Services & Capabilities
- Resource Library
- News & Events
- Contact Us
Introducing the Drug Delivery Systems
Innovative design, global manufacturing, product development expertise
With over 50 years of experience, we are empowering customer success through innovative drug-delivery solutions that improve patient quality of life.
At a glance…
-
>3Bn
Prefillable Sysringes* (PFS) manufactured per year1
-
$2Bn
Yearly revenue (2022)**
-
7500
Associated globally
-
8
Manufacturing plants worldwide
-
Global headquarters
in Pont-de-Claix, France
Product used by more than 500 Pharmaceutical and Biotechnology companies.2
BD customers include 27 of the top 30 pharmaceutical companies in the world.3
~70% of the top 100 pharmaceutical companies around the world rely BD Medical-Pharmaceutical Systems prefillable drug-delivery systems for a wide variety of therapeutic applications.4
BD has generated over 4000 patents that are enforced in more than 25 countries.5
We are focusing on patient well-being
There is a patient at the end of each of the billions of drug delivery devices that we make at BD. That is why we have invested in deep knowledge around patient experience, injection science and combination product development to anticipate customer challenges, manage complexities, and reduce risks. We also invest heavily to support our commitment to quality. Through our extensive global manufacturing network, we aim to offer security of supply and business continuity to our customers.
These, plus our ability to leverage the industry and health authority partnerships of a global healthcare company, are game changing advantages that BD brings to our customers’ drug delivery challenges.
We leverage these assets as we develop innovative solutions that provide peace of mind to customers and contribute to greater patient well-being.
BD Medical - Pharmaceutical Systems manufactures and sells prefillable drug delivery systems to pharmaceutical and biotech companies.
Needle technologies
BD uses proprietary needle technologies to develop needles that optimize your drug delivery.
Explore BD needle technologies
Prefillable syringe systems
BD is uniquely positioned to offer prefillable syringe systems with expertise in drug container interactions, primary container selection and container/device integration for various drug therapies.
Explore our prefillable syringes
Safety and shielding systems
BD offers a wide range of safety and shielding systems that feature innovative needle shielding system technology for your injectable drug
Explore our safety and shielding devices
Self-injection systems
BD partners with you to develop self-injection systems that enable drug administration across a range of volumes and viscosities, leveraging BD primary container technologies and expertise with a focus on reaching the market faster.
Explore our self-injection systems
Add ons and components
To fulfill our system approach, we provide a complete set of components for your pre-fillable syringe systems.
Explore our add ons and components
A history of innovation and market leadership
2022
BD Effivax™ Glass Prefillable Syringe
2021
BD SCF™ PremiumCoat® Plunger Stopper
2021
BD Libertas™ Wearable Injector
2021
BD Evolve™ On-body Injector
2021
BD Neopak™ XtraFlow™Glass Prefillable Syringe
2019
ZebraSci combination product services
2018
BD Hylok™ Glass Prefillable Syringe
2018
BD Neopak™ XSi™ Glass Prefillable Syringe
2014
BD Hypak™ for Vaccines Glass Prefillable Syringe
2013
BD UltraSafe Plus™ 1mlL Passive Needle Guard
2013
BD Sterifill Advance™ 50ml Polymer Prefillable Syringe
2013
BD Neopak™ Glass Prefillable Syringe
2012
BD acquires Safety Syringes Inc.
2012
BD Vystra™ Disposable Pen
2011
BD AutoShield Duo™ Safety Pen Needle
2010
BD Physioject™ Disposable Autoinjector
2009
BD Hypak™ for Biotech Glass Prefillable Syringe
2004
BD Hypak Physiolis™ Glass Prefillable Syringe
2003
BD Sterifill™ Polymer Prefillable Syringe
2001
BD Eclipse™ Needle Shielding System
2000
BD Accuspray™ Nasal Spray System
2000
BD SCF™ FluroTec® Plunger Stoppers
1998
5-bevel needle
1998
BD Uniject™ Auto-Disable Prefillable Injection System
1996
BD Sterifill™ Polymer Prefillable Syringe
1996
BD SafetyGlide™ Needle Shielding System
1990
Polypropylene corrugated materials
1975
First SCF Filling process
1954
BD Hypak™ Glass Disposable Syringe
Honors and Recognition
2022 - Ease of Use℠ Award
BD Physioject™ - recognized by the Arthritis Foundation®
2021 – Vaccine Industry Excellence
Best Production/Process Development
2021 – Frost & Sullivan
BD Intevia™ - Best Practices Award
2020 – Derwent
Top 100 Global Innovator
2019 – Good Design® Award
BD Libertas™ wins prestigious Good Design® Award
2015 – Thomson Reuters
Top 100 Global Innovators
2015 – PDMA OCI
Outstanding Corporate Innovator
2015 – Fortune
World’s Most Admired Companies
* PFS containers
** BD Annual report 2022
- BDM-PS Financial file November 2022, “Actually FY22” Permiter.
- BDM-PS Financial file November 2022, “Actually FY22” Permiter.
- BD Customers compared to Evaluate Pharma ranking FY2019
- IQVIA: IQVIA dataset extracted on March 11th, 2021, from the IQVIA Smart MIDAS' on-line platform, includes WW sales of injectable drugs. Top 100 Corporation (based on IQVIA standard units 2020) selling PFS, Autoinjectors or Pens. TA included: Acute biologics, Anticoagulants, Chronic, Small molecules, Vaccines
- BDM-PS Patents – In force – Worldwide – October 2021.
- IQVIA-based analysis and BD SAP ECC, SAP legacy, Tracis, Nodum systems [invoicing data]. Franklin Lakes, NJ: Becton, Dickinson and Company; 2016.
- BD SAP ECC, SAP legacy, Tracis, Nodum systems [invoicing data]. Franklin Lakes, NJ: Becton, Dickinson and Company; 2018.
- Benefits of BD prefilled syringes [value dossier]. Franklin Lakes, NJ: Becton, Dickinson and Company; 2017.
- Barrow-Williams T, Burnell R. Autoinjectors: technology advances and market trends. Innovations in Pharmaceutical Technology. August 30, 2007. Accessed September 27, 2018.
- World Health Organization. WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injection in health care settings. Published 2016. Accessed September 27, 2018.
- BD Hylok Human Factor study [Internal report]. Pont-de-Claix, FR: Becton Dickinson and Company; 2017.
- Schwarzenbach F, Trong MD, Grange L, et al. Results of a human factors experiment of the usability and patient acceptance of a new autoinjector in patients with rheumatoid arthritis. Patient Prefer Adherence. 2014;8:199-209.
Needle technologies
BD uses proprietary needle technologies to develop needles that optimize your drug delivery.
Explore our needle technologies
Prefillable syringe systems
BD is uniquely positioned to offer prefillable syringe systems with expertise in drug container interactions, primary container selection and container/device integration for various drug therapies.
Explore our prefillable syringes
Safety and shielding systems
BD offers a wide range of safety and shielding systems that feature innovative needle shielding system technology for your injectable drug.
Explore our safety and shielding devices
Self-injection systems
BD partners with you to develop self-injection systems that enable drug administration across a range of volumes and viscosities, leveraging BD primary container technologies and expertise with a focus on reaching the market faster.
Explore our self injection systems
Add ons and components
To fulfill our system approach, we provide a complete set of components for your pre-fillable syringe systems.
Explore our add ons and components
Services and Solutions
BD understands the drug development process and objectives at each stage and offers a wide range of services to help develop container/device strategy and life cycle management plan for drugs.
Services
BD Pharmaceutical Services and Solutions are designed to help you achieve your combination product goals, from development to launch.
Explore our services
BD PartnerPath program
BD PartnerPath™ Program aims to support pharmaceutical organizations that value speed to market in combination product development.1
Explore more on BD Partner PathTM program
We’ve built our services and capabilities around a deep understanding of the combination product development process and the key objectives at each stage, from discovery to delivery.
We are committed to partnering for your sustained commercial success.
System Integration
Effective system integration can be critical to the success of combination products for pharmaceutical companies.1
Explore our system integration
Manufacturing excellence
We manufacture our solutions with a strict focus on continuously advancing quality, consistency and capacity.
Explore our manufacturing
- Market Research “Challenges with System Integration" [external study], Franklin Lakes, NJ, USA: GLG 2019
Biologic Drugs
Hospital Treatments
Vaccines
Specialty Pharmaceuticals
Resources
Journal Articles
View research articles published in a journal and written by experts sharing study results that offer you insight into a particular topic.
Learn more
Scientific Posters
View a scientific poster, such as those used for display at BD tradeshows or seminars to provide detailed information on a research topic
Learn more
Brochures
Learn more about order details, product specs, and technical information by viewing a brochure
Learn more
Events
SAE (ex-SMI) Boston
September 13 - 14, 2023
Conference on Wearable Injectors and Connected Devices
Learn more
News and Media
-
Sep 13, 2022BD Effivax™ Glass Prefillable Syringe Features Enhanced Technology that Builds on Company’s Decades of Expertise in the Prefillable Syringe Market and Supports Customers’ Manufacturing Needs FRANKLIN LAKES, N.J. (September 13, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today introduced a next-generation glass prefillable syringe (PFS) that sets a new standard in performance for vaccine PFS with new and tightened specifications for processability, cosmetics, contamination and integrity.1
-
May 18, 2022Companies to work together with the aim of optimizing advanced technologies for use in prefillable syringes FRANKLIN LAKES, N.J. (May 18, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Mitsubishi Gas Chemical Company, Inc. (MGC), a R&D-oriented chemical manufacturer based in Tokyo, Japan, today announced that they have entered into an agreement to investigate further development of OXYCAPT™ - an innovation from MGC that integrates the best of plastic and glass for plastic syringes.
true
